Asmaa M AboulMagd

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Molecular Docking

Signaling Pathway

Small Cell Lung Cancer

Top Venues

Archiv der Pharmazie

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Mohamad Abdel-Aziz, Hamdy M Abdel-Rahman
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. Archiv der Pharmazie (2024)
Aya I Hassaballah, Asmaa M AboulMagd, Magdy M Hemdan, Mohamed H Hekal, Amira A El-Sayed, Paula S Farag
New pyrazolo[3,4- d ]pyrimidine derivatives as EGFR-TK inhibitors: design, green synthesis, potential anti-proliferative activity and P-glycoprotein inhibition. RSC advances 14 (3) (2024)
Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Mohamad Abdel-Aziz, Hamdy M Abdel-Rahman
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. Archiv der Pharmazie 357 (5) (2024)
Aya I Hassaballah, Asmaa M AboulMagd, Magdy M Hemdan, Mohamed H Hekal, Amira A El-Sayed, Paula S Farag
New pyrazolo[3,4- d ]pyrimidine derivatives as EGFR-TK inhibitors: design, green synthesis, potential anti-proliferative activity and P-glycoprotein inhibition. RSC advances 14 (3) (2024)
Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Mohamad Abdel-Aziz, Hamdy M Abdel-Rahman
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma. Archiv der Pharmazie 357 (5) (2024)
Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Hamdy M Abdel-Rahman, Mohamed Abdel-Aziz
Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review. RSC advances 13 (27) (2023)
Amr L AbdelSamad, Mohammed T El-Saadi, Ahmed M Gouda, Asmaa M AboulMagd
Pyrrolizine/indolizine-bearing (un)substituted isoindole moiety: design, synthesis, antiproliferative and MDR reversal activities, and in silico studies. RSC advances 13 (44) (2023)
Malik Suliman Mohamed, Hany A M Elsherief, Hani Mohamed Hafez, Omar Awad Alsaidan, Samil I Alzarea, Asmaa M AboulMagd
Synthesis, antiproliferative activity, and molecular modeling of novel 4-methylcoumarin derivatives and/or nitric oxide donor hybrids. Molecular diversity (2022)
Hanan Y Aati, Ahmed Ismail, Mostafa E Rateb, Asmaa M AboulMagd, Hossam M Hassan, Mona H Hetta
Garcinia cambogia Phenolics as Potent Anti-COVID-19 Agents: Phytochemical Profiling, Biological Activities, and Molecular Docking. Plants (Basel, Switzerland) 11 (19) (2022)
Mohamed Abdelwahab Abdelgawad, Mohammed Elmowafy, Arafa Musa, Mohammad M Al-Sanea, AbdEIAziz A Nayl, Mohammed M Ghoneim, Yasmine M Ahmed, Hossam M Hassan, Asmaa M AboulMagd, Heba F Salem, Nehal F Farid
Development and Greenness Assessment of HPLC Method for Studying the Pharmacokinetics of Co-Administered Metformin and Papaya Extract. Molecules (Basel, Switzerland) 27 (2) (2022)
Yasmin M Ahmed, Raha Orfali, Nehal F Farid, Hossam M Hassan, Mostafa E Rateb, Asmaa M AboulMagd
Partial Synthetic PPARƳ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Yasmin M Ahmed, Mohamed Abdelwahab Abdelgawad, Khaled Shalaby, Mohammed M Ghoneim, Asmaa M AboulMagd, Nehal F Farid, Hossam M Hassan, Asmaa M Othman
Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Mohamed T M Nemr, Asmaa M AboulMagd, Hossam M Hassan, Ahmed A Hamed, Mohamed I A Hamed, Mohamed T Elsaadi
Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. RSC advances 11 (42) (2021)
Momen M Lotfy, Ahmed M Sayed, Asmaa M AboulMagd, Hossam M Hassan, Dalia El Amir, Sameh F Abouzid, Ahmed O El-Gendy, Mostafa E Rateb, Usama Ramadan Abdelmohsen, Hani Alhadrami, Rabab Mohammed
Metabolomic profiling, biological evaluation of Aspergillus awamori , the river Nile-derived fungus using epigenetic and OSMAC approaches. RSC advances 11 (12) (2021)
Nehal F Farid, Amani Morsi, Yasmine M Ahmed, Hossam M Hassan, Asmaa M AboulMagd
Ecological HPLC method for analyzing an antidiabetic drug in real rat plasma samples and studying the effects of concurrently administered fenugreek extract on its pharmacokinetics. RSC advances 11 (8) (2021)
Enas E Eltamany, Usama Ramadan Abdelmohsen, Dina M Hal, Amany K Ibrahim, Hashim A Hassanean, Reda F A Abdelhameed, Tarek A Temraz, Dina Hajjar, Arwa A Makki, Omnia Magdy Hendawy, Asmaa M AboulMagd, Khayrya A Youssif, Gerhard Bringmann, Safwat A Ahmed
Holospiniferoside: A New Antitumor Cerebroside from The Red Sea Cucumber Holothuria spinifera: In Vitro and In Silico Studies. Molecules (Basel, Switzerland) 26 (6) (2021)
Nada M Mohamed, Eslam M H Ali, Asmaa M AboulMagd
Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 M pro inhibitors. RSC advances 11 (8) (2021)
Mostafa A Mansour, Asmaa M AboulMagd, Hamdy M Abdel-Rahman
Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins. RSC advances 10 (56) (2020)
Esraa M Mohamed, Mona H Hetta, Mostafa E Rateb, Mohamed A Selim, Asmaa M AboulMagd, Farid A Badria, Usama Ramadan Abdelmohsen, Hani A Alhadrami, Hossam M Hassan
Bioassay-Guided Isolation, Metabolic Profiling, and Docking Studies of Hyaluronidase Inhibitors from Ravenala madagascariensis. Molecules (Basel, Switzerland) 25 (7) (2020)
Mohammed S Hifnawy, Mahmoud A Aboseada, Hossam M Hassan, Asmaa M AboulMagd, Adel F Tohamy, Samraa H Abdel-Kawi, Mostafa E Rateb, El Moataz Bellah El Naggar, Miaomiao Liu, Ronald J Quinn, Hani A Alhadrami, Usama Ramadan Abdelmohsen
Testicular Caspase-3 and β-Catenin Regulators Predicted via Comparative Metabolomics and Docking Studies. Metabolites 10 (1) (2020)
Asmaa M AboulMagd, Hossam M Hassan, Ahmed M Sayed, Usama Ramadan Abdelmohsen, Hamdy M Abdel-Rahman
Saccharomonosporine A inspiration; synthesis of potent analogues as potential PIM kinase inhibitors. RSC advances 10 (12) (2020)
Ahmed M Sayed, Amira R Khattab, Asmaa M AboulMagd, Hossam M Hassan, Mostafa E Rateb, Hala Zaid, Usama Ramadan Abdelmohsen
Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale. RSC advances 10 (34) (2020)
Reda F A Abdelhameed, Enas E Eltamany, Dina M Hal, Amany K Ibrahim, Asmaa M AboulMagd, Tarfah Al-Warhi, Khayrya A Youssif, Adel M Abd El-Kader, Hashim A Hassanean, Shaimaa Fayez, Gerhard Bringmann, Safwat A Ahmed, Usama Ramadan Abdelmohsen
New Cytotoxic Cerebrosides from the Red Sea Cucumber Holothuria spinifera Supported by In-Silico Studies. Marine drugs 18 (8) (2020)
Abeer H Elmaidomy, Rabab Mohammed, Asmsaa I Owis, Mona H Hetta, Asmaa M AboulMagd, Abu Bakar Siddique, Usama Ramadan Abdelmohsen, Mostafa E Rateb, Khalid A El Sayed, Hossam M Hassan
Triple-negative breast cancer suppressive activities, antioxidants and pharmacophore model of new acylated rhamnopyranoses from Premna odorata . RSC advances 10 (18) (2020)
Radwa Taher Mohie El-Dien, Sherif A Maher, Usama Ramadan Abdelmohsen, Asmaa M AboulMagd, Mostafa Ahmed Fouad, Mohamed Salah Kamel
Antiulcer secondary metabolites from Elaeocarpus grandis , family Elaeocarpaceae, supported by in silico studies. RSC advances 10 (57) (2020)